Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
The Biochemical Journal
|
November 1, 1971
Biochemical adaptation of rat liver in response to marginal oxygen toxicity
R R Gorman, J P Jordan, J B Simmons, et al.
The Journal of Biological Chemistry
|
November 25, 1984
Biosynthesis and metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid by human umbilical vein endothelial cells
N K Hopkins, T D Oglesby, G L Bundy, et al.
Journal of Clinical Pharmacology
|
January 1, 1989
Thromboxane synthase activity and platelet function after furegrelate administration in man
J S Mohrland, J T Vander Lugt, R R Gorman, et al.
The American Journal of Physiology
|
April 1, 1989
Regulation of Na+-H+ exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene
N E Owen, J Knapik, F Strebel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1993
2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity
C W Benjamin, A H Lin, J Morris, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1983
Synthesis and structure-activity relationship of novel stable prostacyclin analogs
P A Aristoff, A W Harrison, J W Aiken, et al.
Journal of Medicinal Chemistry
|
August 1, 1986
Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids
R A Johnson, E G Nidy, J W Aiken, et al.
Prostaglandins
|
December 1, 1979
Prostacyclin stimulation of dog arterial cyclic AMP levels
O V Miller, J W Aiken, D P Hemker, et al.
Journal of Medicinal Chemistry
|
October 15, 1993
Tröger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity
R A Johnson, R R Gorman, R J Wnuk, et al.
Prostaglandins
|
January 1, 1975
Prostaglandin d2 as a potential antithrombotic agent
E E Nishizawa, W L Miller, R R Gorman, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
The Biochemical Journal
|
November 1, 1971
Biochemical adaptation of rat liver in response to marginal oxygen toxicity
R R Gorman, J P Jordan, J B Simmons, et al.
The Journal of Biological Chemistry
|
November 25, 1984
Biosynthesis and metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid by human umbilical vein endothelial cells
N K Hopkins, T D Oglesby, G L Bundy, et al.
Journal of Clinical Pharmacology
|
January 1, 1989
Thromboxane synthase activity and platelet function after furegrelate administration in man
J S Mohrland, J T Vander Lugt, R R Gorman, et al.
The American Journal of Physiology
|
April 1, 1989
Regulation of Na+-H+ exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene
N E Owen, J Knapik, F Strebel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1993
2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity
C W Benjamin, A H Lin, J Morris, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1983
Synthesis and structure-activity relationship of novel stable prostacyclin analogs
P A Aristoff, A W Harrison, J W Aiken, et al.
Journal of Medicinal Chemistry
|
August 1, 1986
Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids
R A Johnson, E G Nidy, J W Aiken, et al.
Prostaglandins
|
December 1, 1979
Prostacyclin stimulation of dog arterial cyclic AMP levels
O V Miller, J W Aiken, D P Hemker, et al.
Journal of Medicinal Chemistry
|
October 15, 1993
Tröger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity
R A Johnson, R R Gorman, R J Wnuk, et al.
Prostaglandins
|
January 1, 1975
Prostaglandin d2 as a potential antithrombotic agent
E E Nishizawa, W L Miller, R R Gorman, et al.
Page
of 11